Zoetis Inc Stock Performance
Zoetis Inc, a leading animal health medicines and vaccines company, has experienced a moderate increase in its stock price over the past year. The company’s stock price has ranged from a recent high of approximately $200 to a low of around $140.
Market Value and Price-to-Earnings Ratio
The company’s market value remains substantial, with a price-to-earnings ratio that is relatively high.
Investment Firm UBS Maintains Neutral Rating
UBS, an investment firm, has maintained its neutral rating for Zoetis Inc. The firm cited the company’s focus on a new flea treatment from Merck as a key factor in its decision.
Impact on Stock Performance
This development has likely contributed to the company’s stable stock performance. Investors are awaiting further updates on Zoetis’ product offerings and market prospects.
Recent Stock Price Range
- Recent high: approximately $200
- Recent low: around $140